Table 1 List of Clinical Trials Evaluating the Cardiovascular Efficacy and Safety of GLP-1 RAs GLP-1 RA, glucagon-like peptide-1 receptor agonist
The Medicare GLP-1 Bridge seeks to test whether providing access to GLP-1 products at a uniform, CMS-negotiated net price will help improve beneficiary outcomes and reduce long-term Medicare spending, Kelly Strachan, CMS health insurance specialist and Innovation Center fellow, said, according to The Hill
A comprehensive proteomic study of platelets in patients with T2DM and mild cognitive impairment (T2DM-MCI) versus those without (T2DM-nMCI) revealed that differentially expressed proteins are primarily involved in amyloidosis, mitochondrial autophagy, and insulin signaling pathways (Yu et al., 2021)
Rats had ad libitum access to water and SD (Picolab, rodent diet 5053) until 10 months of age in which they were divided into weight-matched groups within each sex, and fed a SD (Picolab, rodent diet 5053) or WD (Research Diets (RD) Western Diet, D12079B, Research Diets Inc., New Brunswick, NJ, USA) for the following 8 weeks of the experiment as described below and demonstrated in Figure 1A
